Literature DB >> 8719827

Revisional lumbar microdiscectomy: an analysis of operative findings and clinical outcome.

N Patel1, I K Pople, B H Cummins.   

Abstract

Forty-one consecutive patients who underwent a revision microlumbar exploration for recurrent or persistent sciatica were reviewed retrospectively to analyse the operative findings and assess the clinical outcome following surgery. Thirty-three (80%) patients were found to have a recurrent intervertebral disc protrusion at the previous site, two patients had a disc herniation at a new site, one had severe perineural scarring, two had lateral recess stenosis, one patient had undergone previous exploration at an incorrect site and in two patients no cause for ongoing symptoms was found. Nineteen of the 33 patients with a re-prolapse presented with persistent or recurrent sciatica within 1 year of their first operation. The other 14 patients presented with a late re-prolapse (after 1 year) and their clinical outcome was better than for those patients with an early re-prolapse (12/14 vs 11/19 satisfactory result, respectively). The result of operating on patients with a late re-prolapse was comparable to the 80-95% satisfactory outcomes following primary lumbar microdiscectomy reported by other authors.

Entities:  

Mesh:

Year:  1995        PMID: 8719827     DOI: 10.1080/02688699550040684

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  2 in total

1.  What is the Rate of Revision Discectomies After Primary Discectomy on a National Scale?

Authors:  Sohrab S Virk; Ashish Diwan; Frank M Phillips; Harvinder Sandhu; Safdar N Khan
Journal:  Clin Orthop Relat Res       Date:  2017-08-28       Impact factor: 4.176

2.  Clinical results of XMR-assisted percutaneous transforaminal endoscopic lumbar discectomy.

Authors:  Gun Choi; Hitesh N Modi; Nicolas Prada; Tae-Joon Ahn; Sung Hee Myung; Mi Sun Gang; Sang-Ho Lee
Journal:  J Orthop Surg Res       Date:  2013-05-25       Impact factor: 2.359

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.